tobramycin and Disease Models, Animal

Topics: Animals; Anti-Bacterial Agents; Ceftazidime; Ciprofloxacin; Disease Models, Animal; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Female; Humans; In Vitro Techniques; Lung; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Mutation; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin

Topics: Administration, Inhalation; Aerosols; Animals; Anti-Bacterial Agents; Aztreonam; Disease Models, Animal; Female; Levofloxacin; Lung Diseases; Mice; Microbial Sensitivity Tests; Ofloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin

Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection

Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Humans; Hydrogen-Ion Concentration; Mice; Microbial Sensitivity Tests; Nebramycin; Pyelonephritis; Rats; Treatment Outcome; Urinary Tract Infections

Topics: Animals; Anti-Bacterial Agents; Biofilms; Disease Models, Animal; Liquid Crystals; Mice; Nanoparticles; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin; Wound Infection

Topics: Agar; Alginates; Animals; Anti-Bacterial Agents; Ciprofloxacin; Disease Models, Animal; Lung; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections; Tobramycin

Topics: Alginates; Animals; Biofilms; Cystic Fibrosis; Disease Models, Animal; Female; Mice; Mice, Inbred BALB C; Pseudomonas aeruginosa; Tobramycin

Topics: Adenosine Triphosphate; Aminoglycosides; Animals; Anti-Bacterial Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Enterococcus faecalis; Indoles; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Osmotic Pressure; Staphylococcal Infections; Staphylococcus aureus; Staphylococcus epidermidis; Streptococcus pyogenes; Tobramycin; Wound Healing

Topics: Animals; Dexamethasone; Disease Models, Animal; Drug Therapy, Combination; Extracellular Traps; Keratitis; Male; Mice; Mice, Inbred C57BL; Neutrophils; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin

Topics: Animals; Cefuroxime; Disease Models, Animal; Endotoxins; Escherichia coli; Escherichia coli Infections; Inflammation; Interleukin-10; Interleukin-6; Multiple Organ Failure; Organ Dysfunction Scores; Penicillin-Binding Proteins; Prospective Studies; Sepsis; Swine; Tobramycin; Tumor Necrosis Factor-alpha

Topics: Animals; Biofilms; Disease Models, Animal; Mice; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolones; Quorum Sensing; Tobramycin

Topics: Animals; Anti-Bacterial Agents; Burkholderia cenocepacia; Burkholderia Infections; Cytokines; Disease Models, Animal; Drug Evaluation, Preclinical; Humans; Liver; Lung; Mice; Mice, Inbred BALB C; Pneumonia; Respiratory Tract Infections; Spleen; Tobramycin

Topics: Animals; Biofilms; Cystic Fibrosis; Disease Models, Animal; Intramolecular Oxidoreductases; Macrophage Migration-Inhibitory Factors; Mice; Pseudomonas aeruginosa; Recombinant Proteins; Tobramycin

Topics: Animals; Anti-Bacterial Agents; Cefuroxime; Disease Models, Animal; Drug Therapy, Combination; Endotoxins; Escherichia coli Infections; Female; Inflammation; Interleukin-6; Leukocyte Count; Male; Multiple Organ Failure; Sepsis; Swine; Tobramycin; Tumor Necrosis Factor-alpha

Topics: Animals; Anti-Bacterial Agents; Biofilms; Colistin; Colonic Neoplasms; Colony Count, Microbial; Disease Models, Animal; Drug Administration Schedule; Drug Dosage Calculations; Drug Therapy, Combination; Female; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin; Treatment Outcome

Topics: Animals; Anti-Bacterial Agents; Calcium Phosphates; Disease Models, Animal; Drug Delivery Systems; Humans; Male; Osteomyelitis; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Tobramycin

Topics: Animals; Anti-Bacterial Agents; Biofilms; Burns; Culture Media; Disease Models, Animal; Fermentation; Humans; Pseudomonas aeruginosa; Pseudomonas Infections; Pyruvic Acid; Staphylococcus aureus; Swine; Tobramycin

Topics: Animals; Anti-Bacterial Agents; Azithromycin; Burns; Ciprofloxacin; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Female; Male; Mice; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin; Treatment Outcome; Wound Infection

Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Drug Interactions; Drug Therapy, Combination; Female; Humans; Lung; Meropenem; Mice; Microbial Sensitivity Tests; Models, Theoretical; Pneumonia, Bacterial; Pseudomonas aeruginosa; Thienamycins; Tobramycin; Treatment Outcome

Topics: Absorbable Implants; Administration, Topical; Animals; Anti-Bacterial Agents; Disease Models, Animal; Drug Carriers; Femoral Fractures; Fractures, Open; Gels; Gentamicins; Polymethyl Methacrylate; Rats; Staphylococcal Infections; Staphylococcus aureus; Surgical Wound Infection; Tobramycin; Vancomycin

Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Drug Delivery Systems; Male; Microspheres; Prostheses and Implants; Prosthesis Implantation; Prosthesis-Related Infections; Rabbits; Random Allocation; Reference Values; Sensitivity and Specificity; Staphylococcal Infections; Tobramycin; Treatment Outcome

Topics: Animals; Anti-Bacterial Agents; Biofilms; Disease Models, Animal; Drug Delivery Systems; Fluorocarbons; Lung; Male; Pseudomonas aeruginosa; Pseudomonas Infections; Rats; Rats, Sprague-Dawley; Surface Tension; Time Factors; Tobramycin; Viscosity

Topics: Animals; Anti-Bacterial Agents; Bacteremia; Bacterial Load; Cefuroxime; Critical Care; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Female; Humans; Immunity, Innate; Liver; Male; Sepsis; Spleen; Swine; Tobramycin

Topics: Animals; Anti-Infective Agents; Biofilms; Cell Line, Tumor; Colistin; Cystic Fibrosis; Disease Models, Animal; Female; Lung Diseases; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin

Topics: Animals; Anti-Bacterial Agents; Aortic Valve; Bacterial Load; Cytokines; Disease Models, Animal; Endocarditis, Bacterial; Myocardium; Rats, Wistar; Spleen; Staphylococcal Infections; Staphylococcus aureus; Tobramycin; Treatment Outcome

Topics: Animals; Anti-Bacterial Agents; Bacteriocins; Disease Models, Animal; Female; Lung; Lung Diseases; Mice; Mice, Inbred C57BL; Pseudomonas aeruginosa; Pseudomonas Infections; Pyocins; Species Specificity; Tobramycin

Topics: Animals; Anti-Bacterial Agents; Cephalosporins; Colistin; Culture Media; Disease Models, Animal; Drug Administration Schedule; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Tobramycin; Treatment Outcome

Topics: A549 Cells; Animals; Biofilms; Burkholderia cenocepacia; Burkholderia Infections; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Therapy, Combination; Econazole; Female; Humans; Mice; Mice, Inbred BALB C; Miconazole; Pneumonia, Bacterial; Tobramycin

Topics: Analysis of Variance; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Cornea; Corneal Stroma; Corneal Ulcer; Data Interpretation, Statistical; Disease Models, Animal; Female; Gentamicins; Ofloxacin; Prospective Studies; Pseudomonas Infections; Rabbits; Tobramycin; Treatment Outcome

Topics: Acetylglucosaminidase; Acute Kidney Injury; Animals; Anti-Bacterial Agents; Biopsy; Creatinine; Cystatin C; Disease Models, Animal; Electrolytes; Endotoxins; Escherichia coli; Kidney; Kidney Function Tests; Microscopy, Electron, Transmission; Swine; Systemic Inflammatory Response Syndrome; Tobramycin; Water-Electrolyte Balance

Topics: Animals; Anti-Bacterial Agents; Chemokine CXCL2; Colony Count, Microbial; Cystic Fibrosis; Disease Models, Animal; Female; Granulocyte Colony-Stimulating Factor; Humans; Lung; Mice; Mice, Inbred BALB C; Pneumonia, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections; Severity of Illness Index; Time Factors; Tobramycin

Topics: Acute Kidney Injury; Aminoglycosides; Animals; Anti-Bacterial Agents; Creatinine; Cystatin C; Disease Models, Animal; Dose-Response Relationship, Drug; Humans; Intensive Care Units; Kidney Function Tests; Swine; Systemic Inflammatory Response Syndrome; Tobramycin; Treatment Outcome; Water-Electrolyte Balance

Topics: Administration, Topical; Animals; Anti-Bacterial Agents; Cefazolin; Ciprofloxacin; Colony Count, Microbial; Corneal Stroma; Corneal Ulcer; Disease Models, Animal; Drug Resistance, Bacterial; Eye Infections, Bacterial; Levofloxacin; Ofloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Tobramycin; Vancomycin

Topics: Adenoviridae; Adenoviridae Infections; Animals; Anti-Infective Agents, Local; Cidofovir; Conjunctiva; Conjunctivitis, Viral; Cytosine; Dexamethasone; Disease Models, Animal; Drug Therapy, Combination; Ophthalmic Solutions; Organophosphonates; Pharmaceutical Preparations; Povidone-Iodine; Rabbits; Tobramycin; Treatment Outcome; Viral Plaque Assay

Topics: Animals; Anti-Bacterial Agents; Colony Count, Microbial; Cornea; Dexamethasone; Disease Models, Animal; Drug Therapy, Combination; Eye Infections, Bacterial; Keratitis; Polysaccharides, Bacterial; Prednisolone; Pseudomonas Infections; Rabbits; Tobramycin

Topics: Animals; Ciprofloxacin; Disease Models, Animal; Drug Resistance, Bacterial; Drug Therapy, Combination; Microbial Sensitivity Tests; Mutation; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Tobramycin

Topics: Administration, Inhalation; Animals; Anti-Bacterial Agents; Bronchoalveolar Lavage Fluid; Cricetinae; Disease Models, Animal; Drug Synergism; Female; Humans; Lung; Mesocricetus; Muramidase; Neutrophils; Pneumonia, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections; Recombinant Proteins; Tobramycin

Topics: Animals; Anti-Bacterial Agents; Bacterial Load; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Female; Foreign Bodies; Histocytochemistry; Mice; Mice, Inbred BALB C; Peritonitis; Pseudomonas aeruginosa; Pseudomonas Infections; Quorum Sensing; Tobramycin

Topics: Amikacin; Animals; Anti-Bacterial Agents; Bacterial Load; Disease Models, Animal; Drug Administration Schedule; Drug Evaluation, Preclinical; Endocarditis, Bacterial; Enterococcus faecalis; Female; Gentamicins; Gram-Positive Bacterial Infections; Netilmicin; Rabbits; Time Factors; Tobramycin

Topics: Animals; Anti-Bacterial Agents; Body Fluids; Disease Models, Animal; Dosage Forms; Fasciotomy; Female; Femoral Fractures; Fractures, Open; Male; Microspheres; Negative-Pressure Wound Therapy; Polymethyl Methacrylate; Swine; Tobramycin; Treatment Outcome; Vancomycin

Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Drug Implants; Female; Fibrin Tissue Adhesive; Microbial Sensitivity Tests; Osteomyelitis; Polymethyl Methacrylate; Rabbits; Tissue Adhesives; Tobramycin; Vasodilator Agents

Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; Biofilms; Catheterization; Ciprofloxacin; Colony Count, Microbial; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Monitoring; Luminescent Measurements; Mice; Rifampin; Staphylococcus aureus; Tobramycin

Topics: Animals; Anti-Bacterial Agents; Antibiotic Prophylaxis; Disease Models, Animal; Intubation; Klebsiella Infections; Klebsiella pneumoniae; Pneumonia, Bacterial; Prospective Studies; Rats; Rats, Wistar; Tobramycin; Ventilators, Mechanical

Topics: Administration, Topical; Animals; Anti-Bacterial Agents; Cornea; Corneal Ulcer; Disease Models, Animal; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Glucocorticoids; Mice; Mice, Inbred C57BL; Ofloxacin; Prednisolone; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin

Topics: Animals; Anti-Bacterial Agents; Biocompatible Materials; Cefazolin; Disease Models, Animal; Drug Carriers; Infusions, Parenteral; Lactic Acid; Male; Microspheres; Osteomyelitis; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Polymethyl Methacrylate; Rabbits; Radiography; Radius; Staphylococcal Infections; Tobramycin

Topics: Animals; Anti-Bacterial Agents; Cefepime; Cephalosporins; Disease Models, Animal; Drug Therapy, Combination; Endocarditis, Bacterial; Female; Humans; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Tobramycin

Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Colistin; Disease Models, Animal; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Humans; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Pneumonia, Bacterial; Rifampin; Tobramycin

Topics: Animals; Anti-Bacterial Agents; Ciprofloxacin; Disease Models, Animal; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Female; Lung; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Mutation; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin

Topics: Animals; Anti-Bacterial Agents; Bone Diseases, Infectious; Calcium Sulfate; Colony Count, Microbial; Disease Models, Animal; Drug Implants; Fractures, Bone; Goats; Male; Microspheres; Polymethyl Methacrylate; Staphylococcus aureus; Tobramycin; Treatment Outcome

Topics: Animals; Anti-Bacterial Agents; Biofilms; Cefuroxime; Chronic Disease; Ciprofloxacin; Disease Models, Animal; Interleukin-1; Interleukin-10; Interleukin-6; Interleukins; Male; Osteomyelitis; Rats; Rats, Wistar; Staphylococcal Infections; Tibia; Tobramycin; Vancomycin

Topics: Animals; Anti-Bacterial Agents; Bone Morphogenetic Protein 7; Bone Morphogenetic Proteins; Bone Substitutes; Delayed-Action Preparations; Disease Models, Animal; Drug Combinations; Femoral Fractures; Femur; Fracture Healing; Radiography; Rats; Rats, Sprague-Dawley; Tobramycin; Transforming Growth Factor beta; Transplantation, Homologous; Treatment Outcome

Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Colony Count, Microbial; Corneal Ulcer; Disease Models, Animal; Eye Infections, Bacterial; Female; Fluoroquinolones; Gatifloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Serratia Infections; Serratia marcescens; Tobramycin

Topics: Administration, Topical; Animals; Anti-Infective Agents, Local; Cefazolin; Chlorhexidine; Ciprofloxacin; Colony Count, Microbial; Cornea; Disease Models, Animal; Drug Combinations; Eye Infections, Bacterial; Keratitis; Microbial Sensitivity Tests; Ophthalmic Solutions; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Tobramycin

Topics: Animals; Anti-Bacterial Agents; Dexamethasone; Disease Models, Animal; Drug Compounding; Eye Infections, Bacterial; Keratitis; Polysaccharides, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Random Allocation; Tobramycin; Treatment Outcome

Topics: Amikacin; Animals; Anti-Bacterial Agents; Disease Models, Animal; Gentamicins; Guinea Pigs; Keratitis; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin

Topics: Aminoglycosides; Animals; Biological Assay; Carbenicillin; Disease Models, Animal; Dogs; Drug Interactions; Drug Stability; Kidney Diseases; Penicillinase; Radioimmunoassay; Tobramycin

Topics: Acute Disease; Administration, Oral; Amphotericin B; Animals; Bacteria; Bacterial Infections; Bacterial Physiological Phenomena; Cecal Diseases; Cefotaxime; Colistin; Disease Models, Animal; Drug Therapy, Combination; Imipenem; Injections, Intravenous; Kidney Diseases; Male; Necrosis; Pancreas; Pancreatic Diseases; Pancreatitis; Rats; Rats, Sprague-Dawley; Survival Rate; Tobramycin

Topics: Animals; Anti-Bacterial Agents; Ciprofloxacin; Colony Count, Microbial; Cornea; Dexamethasone; Disease Models, Animal; Drug Therapy, Combination; Eye Infections, Bacterial; Glucocorticoids; Keratitis; Ophthalmic Solutions; Prednisolone; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Tobramycin

Topics: Animals; Disease Models, Animal; Drug Therapy, Combination; Endocarditis, Bacterial; Female; Injections, Intramuscular; Penicillin G Procaine; Rabbits; Species Specificity; Streptococcal Infections; Streptococcus; Teicoplanin; Time Factors; Tobramycin

Topics: Administration, Topical; Animals; Cefazolin; Ciprofloxacin; Colony Count, Microbial; Cornea; Disease Models, Animal; Drug Therapy, Combination; Eye Infections, Bacterial; Keratitis; Ophthalmic Solutions; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Tobramycin

Topics: Animals; Antithrombin III; Bacteremia; Disease Models, Animal; Disseminated Intravascular Coagulation; Drug Therapy, Combination; Female; Klebsiella Infections; Klebsiella pneumoniae; Lipopolysaccharides; Rats; Tobramycin

Topics: Animals; Anti-Bacterial Agents; Bacterial Translocation; Burns; Cell Division; Cells, Cultured; Colistin; Digestive System; Disease Models, Animal; Endotoxins; Flucytosine; Immunity, Cellular; Immunosuppression Therapy; Interleukin-2; Intestines; Lymphocyte Subsets; Rats; Rats, Sprague-Dawley; Spleen; Tobramycin

Topics: Animals; Anti-Bacterial Agents; Biomarkers; Ceftazidime; Cephalosporins; Diarrhea; Disease Models, Animal; Female; Guinea Pigs; Imipenem; Meropenem; Movement Disorders; Neutropenia; Predictive Value of Tests; Pseudomonas Infections; Regression Analysis; Respiration; Thienamycins; Time Factors; Tobramycin; Weight Loss

Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Bacterial Translocation; Colistin; Culture Techniques; Digestive System; Disease Models, Animal; Female; Food, Formulated; Fungi; Gram-Negative Bacteria; Intestinal Mucosa; Parenteral Nutrition, Total; Probability; Rats; Rats, Inbred Strains; Tobramycin

Topics: Animals; Anti-Bacterial Agents; Bone Cements; Bone Nails; Disease Models, Animal; Drug Implants; Equipment Contamination; External Fixators; Fracture Fixation; Goats; Materials Testing; Polymethyl Methacrylate; Reference Values; Surgical Wound Infection; Tobramycin

Topics: Aerosols; Animals; Anti-Bacterial Agents; Chronic Disease; Disease Models, Animal; Drug Carriers; Liposomes; Lung Diseases; Powders; Pseudomonas Infections; Rats; Rats, Sprague-Dawley; Temperature; Tobramycin

Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Biofilms; Cefuroxime; Cephalosporins; Chronic Disease; Ciprofloxacin; Disease Models, Animal; Male; Osteomyelitis; Rats; Rats, Wistar; Staphylococcal Infections; Staphylococcus aureus; Tibia; Tobramycin; Vancomycin

Topics: Administration, Topical; Animals; Anti-Bacterial Agents; Aqueous Humor; Carbenicillin; Cornea; Disease Models, Animal; Drug Administration Schedule; Drug Evaluation, Preclinical; Gentamicins; Guinea Pigs; Humans; Injections, Intramuscular; Keratitis; Kinetics; Male; Polymyxins; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin

Topics: Administration, Topical; Animals; Anti-Bacterial Agents; Disease Models, Animal; Guinea Pigs; Humans; Injections; Injections, Intramuscular; Keratitis; Kinetics; Pseudomonas Infections; Rabbits; Tobramycin

Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Gentamicins; Kidney; Kidney Tubular Necrosis, Acute; Rats; Tobramycin

Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Eye Diseases; Gentamicins; Humans; Keratitis; Male; Microbial Sensitivity Tests; Proteus; Proteus Infections; Proteus mirabilis; Proteus vulgaris; Rabbits; Tobramycin

Topics: Ampicillin; Animals; Anti-Bacterial Agents; Disease Models, Animal; Lung; Peritonitis; Rats; Respiratory Distress Syndrome; Tobramycin

Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Cephalexin; Disease Models, Animal; Drug Synergism; Female; Injections, Intramuscular; Pyelonephritis; Rats; Tobramycin

Topics: Animals; Critical Illness; Disease Models, Animal; Drug Monitoring; Evaluation Studies as Topic; Extracorporeal Membrane Oxygenation; Infusions, Intravenous; Least-Squares Analysis; Metabolic Clearance Rate; Prospective Studies; Sheep; Tissue Distribution; Tobramycin

Topics: Animals; Biological Dressings; Collagen; Colony Count, Microbial; Cornea; Corneal Ulcer; Delayed-Action Preparations; Disease Models, Animal; Eye Infections, Bacterial; Ophthalmic Solutions; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Tobramycin

Topics: Administration, Topical; Animals; Colony Count, Microbial; Cornea; Corneal Ulcer; Disease Models, Animal; Drug Carriers; Eye Infections, Bacterial; Fibrin; Liposomes; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Random Allocation; Tobramycin

Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cornea; Disease Models, Animal; Eye Infections, Bacterial; Keratitis; Methylprednisolone; Pneumococcal Infections; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Random Allocation; Recurrence; Streptococcus pneumoniae; Tobramycin

Topics: Administration, Topical; Animals; Aqueous Humor; Chromatography, High Pressure Liquid; Disease Models, Animal; Eye Infections, Bacterial; Keratitis; Ofloxacin; Pseudomonas Infections; Rabbits; Tobramycin

Topics: Animals; Bone Transplantation; Cephalothin; Disease Models, Animal; Mandibular Fractures; Osteomyelitis; Prevotella melaninogenica; Rabbits; Staphylococcus aureus; Tobramycin; Transplantation, Homologous

Topics: Administration, Topical; Animals; Aprotinin; Conjunctiva; Corneal Ulcer; Disease Models, Animal; Drug Administration Routes; Drug Therapy, Combination; Pseudomonas Infections; Rabbits; Tobramycin

Topics: Administration, Topical; Animals; Anti-Inflammatory Agents; Disease Models, Animal; Flurbiprofen; Keratitis; Pharmaceutical Vehicles; Pneumococcal Infections; Prednisolone; Pseudomonas Infections; Rabbits; Tobramycin

Topics: Animals; Anti-Bacterial Agents; Autoradiography; Disease Models, Animal; Endocarditis, Bacterial; Female; Glycopeptides; Myocardium; Penicillins; Rabbits; Teicoplanin; Tobramycin

Topics: Administration, Topical; Animals; Biological Availability; Collagen; Colony Count, Microbial; Cornea; Disease Models, Animal; Eye Infections, Bacterial; Keratitis; Lacrimal Duct Obstruction; Prostheses and Implants; Pseudomonas Infections; Rabbits; Tears; Tobramycin

Topics: Animals; Ceftazidime; Ciprofloxacin; Disease Models, Animal; Meningitis; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Tobramycin

Topics: Animals; Bacterial Infections; Biological Availability; Disease Models, Animal; Eye Diseases; Keratitis; Kinetics; Male; Ophthalmic Solutions; Pseudomonas Infections; Rabbits; Rats; Rats, Inbred Strains; Tears; Tobramycin

Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Bacterial Infections; Disease Models, Animal; Endocarditis, Bacterial; Guinea Pigs; Humans; Pneumonia; Pseudomonas Infections; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Tobramycin

Topics: Animals; Anti-Bacterial Agents; Antibodies, Bacterial; Bacterial Vaccines; Chronic Disease; Combined Modality Therapy; Disease Models, Animal; Drug Evaluation, Preclinical; Male; Mice; Polymyxin B; Pseudomonas aeruginosa; Pseudomonas Infections; Time Factors; Tobramycin